Streetbeat News

Price Targets

RAMP

Evercore ISI Group analyst Kirk Materne maintains an Outperform rating on LiveRamp Holdings (NYSE:RAMP) but lowers the price target from $50 to $40.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:14 pm

ROK

Wells Fargo analyst Joseph O'Dea maintains an Overweight rating on Rockwell Automation (NYSE:ROK) but lowers the price target from $305 to $293.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:13 pm

FROG

JFrog Ltd. (NASDAQ:FROG) reported weaker-than-expected Q2 sales and issued FY24 guidance below estimates. Despite beating earnings per share estimates, the company missed revenue expectations. Analysts have subsequently lowered their price targets, with one downgrade from Outperform to Perform.

Portfolio Pulse from Avi Kapoor

August 08, 2024 | 1:13 pm

OGE

Evercore ISI Group analyst Durgesh Chopra maintains an In-Line rating on OGE Energy (NYSE:OGE) and raises the price target from $36 to $40.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:13 pm

NVST

Evercore ISI Group analyst Elizabeth Anderson maintains an Outperform rating on Envista Holdings (NYSE:NVST) but lowers the price target from $19 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:12 pm

EMR

Wells Fargo analyst Joseph O'Dea maintains an Overweight rating on Emerson Electric (NYSE:EMR) but lowers the price target from $137 to $128.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:12 pm

NI

Evercore ISI Group analyst Durgesh Chopra maintains an Outperform rating on NiSource (NYSE:NI) and raises the price target from $32 to $34.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:11 pm

QSR

TD Cowen analyst Andrew Charles has reiterated a Buy rating on Restaurant Brands International (NYSE:QSR) and maintained a price target of $88.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:11 pm

MNST

Evercore ISI Group analyst Robert Ottenstein maintains an Outperform rating on Monster Beverage (NASDAQ:MNST) but lowers the price target from $65 to $60.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:10 pm

MIRM

Evercore ISI Group analyst Gavin Clark-Gartner maintains an Outperform rating on Mirum Pharmaceuticals (NASDAQ:MIRM) and raises the price target from $62 to $66.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:10 pm